PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

Filter the list
Latest update:
Process:

The List does not contain any Substances.
Data generation and assessment ARN Regulatory risk management
 
((4-phenylbutyl)hydroxyphosphoryl)acetic acid
SQ 26999
412-170-7 83623-61-4 - - - - 1 - - - - Details
(+)-(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one) 430-460-1 133636-82-5 - - - - 1 - - - - Details
(+)-bornan-2-one 207-355-2 464-49-3 - - - - 1 - - - - Details
(+)-N-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutyramide 211-569-1 667-83-4 - - - - 1 - - - - Details
(+/-) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate
PANTERA; QUIZALOFOP-P-TEFURYL
414-200-4 200509-41-7 - - - - - 1 - - - Details
(-)-Methyl (S)-2-chloropropionate 625-379-5 73246-45-4 - - - - 1 - - - - Details
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate 214-619-0 1166-46-7 - - - 1 - 1 - - - Details
(1-methylethylidene)bis(4,1-phenyleneoxy-2,1-ethanediyl) bismethacrylate 246-263-7 24448-20-2 - - - - 1 - - - - Details
(1-methylethylidene)bis(4,1-phenyleneoxy-3,1-propanediyl) bismethacrylate 248-607-1 27689-12-9 - - - - 1 - - - - Details
(1-methylethylidene)bis[4,1-phenyleneoxy(2-hydroxy-3,1-propanediyl)] bismethacrylate 216-367-7 1565-94-2 - - - - 1 - - - - Details
(1-methylethylidene)bis[4,1-phenyleneoxy(2-hydroxy-3,1-propanediyl)] diacrylate 225-144-3 4687-94-9 - - - - 1 - - - - Details
(1R)-1-Naphthylethylamine Hydrochloride 617-358-4 82572-04-1 - - - - 1 - - - - Details
(1R)cyclohex-3-enecarboxylic acid (1S)-1-phenylethylamine 814-700-6 67976-81-2 - - - - 1 - - - - Details
(1R,2R)-cyclohexane-1,2-diamine (2R,3R)-2,3-dihydroxybutanedioic acid 609-759-8 39961-95-0 - - - - 1 - - - - Details
(1R,2S)-2,6-dimethyl-2,3-dihydro-1H-inden-1-amine 700-140-9 752984-24-0 - - - - 1 - - - - Details
(1R,2S)-cyclohexane-1,2-diamine; sulfuric acid 613-794-4 65433-80-9 - - - - 1 - - - - Details
(1S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-one 225-160-0 4695-62-9 - - - - 1 - - - - Details
(1S)-1-NAPHTHYLETHYLAMINE 436-100-1 - - - - - 1 - - - - Details
(1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride 220-384-5 2746-19-2 - - - - 1 - - - - Details
(2-chloro-1,1-dimethylethyl)benzene 208-197-7 515-40-2 - - - - 1 - - - - Details
(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride
QUANTACURE QTX
402-200-7 103430-24-6 - - - - 1 - - - - Details
(2-hydroxypropyl)trimethylammonium 2-ethylhexanoate 263-502-0 62314-22-1 - - - - 1 - - - - Details
(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate;bifenthrin (ISO) 617-373-6 82657-04-3 - - - - - 1 - - - Details
(2-methylpropyl)lithium;isobutyllithium 440-620-2 920-36-5 - - - - 1 - - - - Details
(2RS)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol; mefentrifluconazole - 1417782-03-6 - - - - - 1 - - - Details

Export search results to:

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.